Assess whether RWE can replace or only supplement an RCT (596da5)
August 31, 2026 · SmartSolo
Situation
Clinical-development physician owns RWE can replace or inside a 505(b)(2) program relying on literature plus a bridging study with scientific-advice briefing book as the only packet. An inspector asking for batch records you cannot produce this week is what changed the clock for this Pharma & Life Sciences Pharmacovigilance file.
Decision
Clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study must choose RWE can replace / Only supplement an RCT using scientific-advice briefing book after an inspector asking for batch records you cannot produce this week.
Hypotheses to test
- Clinical-development physician can defend RWE can replace from scientific-advice briefing book after an inspector asking for batch records you cannot produce this week in a Pharma & Life Sciences challenge.
- Clinical-development physician cannot defend RWE can replace from scientific-advice briefing book; Only supplement an RCT is what the extract actually supports after an inspector asking for batch records you cannot produce this week.
- An inspector asking for batch records you cannot produce this week never reached the population in scientific-advice briefing book — reopen intake, do not close RWE can replace or.
- Two facts in scientific-advice briefing book after an inspector asking for batch records you cannot produce this week conflict for clinical-development physician; hold this Pharmacovigilance file.
Analysis required
- Check whether scientific-advice briefing book supports the labeled claim clinical-development physician would keep.
- Map FDA-response timing and owner in a 505(b)(2) program relying on literature plus a bridging study.
- Trace CMC, labeling, or pharmacovigilance facts in scientific-advice briefing book after an inspector asking for batch records you cannot produce this week.
- For this Pharma & Life Sciences Pharmacovigilance file, read scientific-advice briefing book against an inspector asking for batch records you cannot produce this week and write the one fact that would move RWE can replace or for clinical-development physician.
Recommendation
Choose RWE can replace / Only supplement an RCT on this Pharma & Life Sciences / Pharmacovigilance packet (scientific-advice briefing book after an inspector asking for batch records you cannot produce this week). The follow-on Pharmacovigilance action is what clinical-development physician does next: implement the option, assign an owner, and log the missing fact.
Explore more
More Pharma & Life Sciences prompts
- Assess whether RWE can replace or only supplement an RCT (aa9496)
- Assess whether to resubmit, meet, or pause the program (527c67)
- Assess whether the 505(b)(2) bridge is legally and scientifically enough
- Assess whether RWE can replace or only supplement an RCT (3ae840)
- Assess whether a CMO finding is a delay or a refuse-to-file risk (64ebba)
Explore related decision areas
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

